101 related articles for article (PubMed ID: 3953312)
1. Low-dose cytosine arabinoside therapy in a patient with myelofibrosis during transformation to acute non-lymphocytic leukemia.
Jensen MK; Johansen P; Ahlbom G
Acta Med Scand; 1986; 219(1):129-31. PubMed ID: 3953312
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cytosine arabinoside in the treatment of relapsed and refractory acute non-lymphocytic leukaemia.
Krogh Jensen M; Stentoft J
Acta Haematol; 1986; 76(2-3):127-9. PubMed ID: 3101350
[TBL] [Abstract][Full Text] [Related]
3. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemia.
Jensen MK; Ahlbom G
Scand J Haematol; 1985 Mar; 34(3):261-3. PubMed ID: 3992192
[TBL] [Abstract][Full Text] [Related]
4. The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse.
van Prooijen HC; Dekker AW; Punt K
Br J Haematol; 1984 Jun; 57(2):291-9. PubMed ID: 6733049
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C).
Lin SF; Liu HW; Chen TP
Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):45-50. PubMed ID: 2330805
[TBL] [Abstract][Full Text] [Related]
6. High-dose cytosine arabinoside for acute nonlymphocytic leukemia.
Cantin G; Brennan JK
Am J Hematol; 1984 Jan; 16(1):59-66. PubMed ID: 6695910
[TBL] [Abstract][Full Text] [Related]
7. Salvage therapy with low-dose cytosine arabinoside in refractory or relapsed acute non-lymphocytic leukaemia: a report on 25 patients.
Jensen MK; Johansen P; Stentoft J; Jensen MK
Eur J Haematol; 1994 Apr; 52(4):236-9. PubMed ID: 8005235
[TBL] [Abstract][Full Text] [Related]
8. [Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
Palomera L; García Díez I; Woessner S; Velasco F; Torres A
Sangre (Barc); 1988 Jun; 33(3):232-7. PubMed ID: 3175820
[No Abstract] [Full Text] [Related]
9. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblast (AML-MO).
Kanamori H; Tanabe J; Koike T; Hashimoto Y; Matsuzaki M; Kitamura H; Motomura S; Mohri H; Ohkubo T
Am J Hematol; 1994 Jun; 46(2):154-5. PubMed ID: 8172187
[No Abstract] [Full Text] [Related]
11. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
[TBL] [Abstract][Full Text] [Related]
12. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
13. Low dose cytosine arabinoside used to induce remission in acute myelofibrosis.
Whitehead S; Geary CG
Br J Haematol; 1984 Oct; 58(2):375-6. PubMed ID: 6477839
[No Abstract] [Full Text] [Related]
14. [Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
Moriyama Y; Urushiyama M; Ohnishi M; Koyama S; Hirosawa H; Hanano M; Fuse I; Takai K; Nagayama R; Fujiwara M; Kishi K; Takahashi M; Koike T; Sakai C; Kashimura M; Miura R; Aoyagi A; Sanada M; Hattori A; Shibata A; Shinada S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1549-54. PubMed ID: 6892201
[TBL] [Abstract][Full Text] [Related]
15. Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia.
Alessandrino EP; Orlandi E; Brusamolino E; Lazzarino M; Bernasconi C
Am J Hematol; 1985 Oct; 20(2):191-3. PubMed ID: 4036958
[TBL] [Abstract][Full Text] [Related]
16. Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis.
Kobayashi S; Sakai H; Tomiazwa T; Koiso H; Kim K; Ueki K; Tamura J; Yano S; Naruse T; Karasawa M
J Med; 1999; 30(1-2):101-9. PubMed ID: 10515246
[TBL] [Abstract][Full Text] [Related]
17. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB
Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
Skeel RT; Costello W; Bennett JM; Oken MM; Tobin MS; Bertino JR; Marsh JC; Carbone PP
Cancer; 1980 Jan; 45(2):224-31. PubMed ID: 6985830
[TBL] [Abstract][Full Text] [Related]
19. Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.
Preisler HD; Raza A; Barcos M
Med Oncol Tumor Pharmacother; 1985; 2(2):87-91. PubMed ID: 4058079
[TBL] [Abstract][Full Text] [Related]
20. [The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome].
Yoshida M; Tsunoda S; Akutsu M; Furukawa Y; Takeda K; Akashi M; Komatsu N; Muroi K; Ikeda K; Ohsaka A
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1057-62. PubMed ID: 3566302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
